I have always thought, along with other colleagues for a long time, that you can start identifying groups that have lived with obesity for a very long period of time and they would somehow present differently metabolically and so on, and it would give us an understanding of what treatments would be better for someone, let's say, with long-term obesity versus someone with short-term obesity
Abstract Glucagon-like peptide 1 receptor (GLP1R) agonists, such as semaglutide, drive weight loss by binding to GLP1Rsclassically described as G s -coupled G-protein-coupled receptorsin the brain
The most common GLP-1 side effects are gastrointestinal: nausea, constipation, bloating, diarrhea, etc
(2020) Channeling C1 metabolism toward S-adenosylmethionine-dependent conversion of estrogens to androgens in estrogen-degrading bacteria, mBio , 11 , Wang, Y., Schnell, B., Baumann, S., Mller, R., and Begley, T
Nature Neuroscience
Increasing evidence suggests that Long COVID and ME/CFS are frequently driven by the reactivation of dormant virusesmost notably the Epstein-Barr Virus (EBV), a member of the herpesvirus family